25
IRUS Total
Downloads
  Altmetric

The prevalence of chronic airflow obstruction in three cities in the Nordic-Baltic region

File Description SizeFormat 
YRMED-D-18-00197R1 (1)-Accepted.pdfAccepted version1.5 MBAdobe PDFView/Open
Title: The prevalence of chronic airflow obstruction in three cities in the Nordic-Baltic region
Authors: Broström, E
Jõgi, R
Gislason, T
Benediktsdottir, B
Burney, PGJ
Janson, C
Item Type: Journal Article
Abstract: Background: Chronic airflow obstruction (CAO) is the primary characteristic of Chronic obstructive pulmonary disease (COPD) but is also seen in chronic asthma. Objective: To compare the prevalence of CAO and possible risk factors between Tartu in Estonia, Reykjavik in Iceland and Uppsala in Sweden. Methods: All participants underwent spirometry testing of forced expiratory volume in 1 s (FEV1) and forced vital capacity (FVC) before and after bronchodilation. CAO was defined as post-bronchodilator FEV1/FVC below lower limit of normal. Information on respiratory diseases and smoking status, was obtained through questionnaires administered by trained interviewers. Results: 1037 men and 956 women participated in the study. The prevalence of CAO was lower in women in Tartu compared to the other centres (4.9% vs. 13.4 and 8.7% in Reykjavik and Uppsala, respectively, p = 0.002) while no difference was found for men. A similar picture was seen for the proportion of participants that had smoked 10 pack years or more which was much lower in Tartu for women than in Reykjavik and Uppsala, respectively (13.2% vs. 33.7 and 29.2%, p < 0.001). (Fig. 1). Of the participants with CAO the majority (57–67%) did not have a previous diagnosis of asthma or COPD. Conclusion: The prevalence of CAO was lower in Estonian women than in women from Iceland and Sweden. The reason for this was probably that the Estonian women had smoked less than the female participants from Iceland and Sweden. The majority of those with CAO do not have a diagnosed lung disease.
Issue Date: 1-Oct-2018
Date of Acceptance: 12-Aug-2018
URI: http://hdl.handle.net/10044/1/62269
DOI: https://dx.doi.org/10.1016/j.rmed.2018.08.007
ISSN: 0954-6111
Start Page: 8
End Page: 13
Journal / Book Title: Respiratory Medicine
Volume: 143
Copyright Statement: © 2018 Elsevier Ltd. All rights reserved. This manuscript is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International Licence http://creativecommons.org/licenses/by-nc-nd/4.0/
Sponsor/Funder: Tartu University Hospital
Wellcome Trust
Funder's Grant Number: DHTBX_P19125
085790/Z/08/Z
Keywords: 1102 Cardiovascular Medicine And Haematology
1103 Clinical Sciences
Respiratory System
Publication Status: Published
Online Publication Date: 2018-08-13
Appears in Collections:National Heart and Lung Institute